# NeuroVive Pharmaceutical AB: Form D filing

NeuroVive Pharmaceutical AB, a pharmaceuticals company in 81 Lund, Sweden, filed a Form D with the SEC in 2015. The latest, on May 27, 2015, reports $7.5 million sold of a $25 million offering to 11 investors.

Find out what NeuroVive Pharmaceutical AB does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20NeuroVive%20Pharmaceutical%20AB%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=NeuroVive%20Pharmaceutical%20AB&page=%2Fdata%2Fform-d%2Fcompany%2Fneurovive-pharmaceutical-ab-1643349)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20NeuroVive%20Pharmaceutical%20AB%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=NeuroVive%20Pharmaceutical%20AB&page=%2Fdata%2Fform-d%2Fcompany%2Fneurovive-pharmaceutical-ab-1643349)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: MEDICON VILLAGE SE-223, 81 Lund, Sweden, None
- Phone: +46-46-275 6220
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Sweden
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1643349

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 27, 2015 | New notice | $25,000,000 | $7,462,732 | $17,537,268 | 11 | May 8, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1643349/000114420415033524/0001144204-15-033524-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jan Nilsson | Executive Officer |  |
| Helmuth Malm Von Moltke | Director |  |
| Helena Malm Levander | Director |  |
| Catharina Johansson | Executive Officer |  |
| Arne Malm Ferstad | Director |  |
| Marcus Malm Keep | Director |  |
| Carl Fredrick Olsson | Director |  |
| Mikael Bronnegard | Executive Officer |  |
| Boel Malm Flodgren | Director |  |
| Anna Malm Bernsten | Director |  |
| Eskil Elmer | Executive Officer |  |
| Gregory Batcheller | Executive Officer, Director |  |

[Every Form D from the week of May 25, 2015](https://specstream.ai/data/form-d/week/2015-05-25) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what NeuroVive Pharmaceutical AB reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).